10.1038/ajg.2011.315 Am J Gastroenterol
Fenzi G, Hashizume K, Roudebush CP, DeGroot LJ
Yes Vyleesi is the brand name for PT-141 (bremelanotide), FDA-approved for hypoactive sexual desire disorder in premenopausal women
We partner with practitioners and clinical organizations to ensure that patients gain access to high-quality and cost-effective medications
DPP-4 inhibitors (gliptins) should be stopped as not recommended together, as well as antimotility medications like codeine and loperamide
Certain dietary approaches, such as low carbohydrate and Mediterranean diet are demonstrated to support sustainable weight loss and so before beginning any weight reduction medication, it is critical to talk with a healthcare professional to fully understand the options that are right for you.